Form 4 for VCYT VERACYTE, INC.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001539796-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | VCYT | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +139.1K | 458.4K | +44% | $0 | |
| 2026-03-02 | 2026-02-26 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $38.75 | -35.8K | 422.5K | -8% | -$1.39M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | A | A | 139,074 | $0.00 | 458,373 | D | — | — | (F2) Includes 696 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-02-26 | F | D | 35,841 | $38.75 | 422,532 | D | — | — |